Circassia abandons allergy programme after trial failure

18th April 2017 Uncategorised 0

British biotech Circassia has announced the death of its allergy programme following a second key trial failure, choosing to focus all of its efforts on its respiratory business instead.

More: Circassia abandons allergy programme after trial failure
Source: News